Cost-effectiveness of 6 and 12 months of interferon-alpha therapy for chronic hepatitis C. [electronic resource]
Producer: 19971119Description: 866-74 p. digitalISSN:- 0003-4819
- Adult
- Age Factors
- Aged
- Antiviral Agents -- administration & dosage
- Cost-Benefit Analysis
- Disease Progression
- Drug Administration Schedule
- Hepatitis C, Chronic -- drug therapy
- Humans
- Interferon-alpha -- administration & dosage
- Markov Chains
- Middle Aged
- Quality-Adjusted Life Years
- Sensitivity and Specificity
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.